Stocks
BioMarin Pharmaceutical (BMRN) EBITDA margin US GAAP (year values) |
||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EBITDA margin, % | ? | 7.90% | 12.7% | 12.7% | 22.8% | 17.8% | 14.3% | |
| Changes by years, y/y, % | +5pp | +0pp | +10pp | -5pp | ||||
BioMarin Pharmaceutical. EBITDA margin, %
BioMarin Pharmaceutical. EBITDA margin, changes, pp
BioMarin Pharmaceutical (BMRN) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 35.3% | 38.7% | -0.68% | -0.45% | 20.1% | 14.3% | |
| Changes by years, y/y, % | +14pp | +16pp | -22pp | -27pp | -15pp | |||
| Changes by quarters, q/q, % | +9pp | +3pp | -39pp | +0pp | +21pp | |||
